【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 13
2 Introduction 15
2.1 What Is This Report About? 15
3 Definitions of Markets/Categories Covered 16
3.1 Cardiovascular Devices 16
3.1.1 Cardiac Rhythm Management 16
3.1.2 Cardiovascular Prosthetic Devices 16
3.1.3 Cardiovascular Surgery 16
3.1.4 Prosthetic Heart Valves 16
4 Company Snapshot 17
4.1 Key Facts 17
4.2 Company Overview 17
4.3 Financial Performance 17
4.4 SWOT Snapshot 17
5 Business Description 18
5.1 Business Overview 18
5.2 Cardiovascular 19
5.2.1 Overview 19
5.2.2 Financials 19
5.2.3 Market View 19
5.3 Major Products and Services 20
5.3.1 Overview 20
6 History 21
7 SWOT Analysis 26
7.1 Overview 26
7.2 Sorin S.p.A. Strengths 26
7.2.1 Geographical Diversity 26
7.2.2 Focused Research and Development Activities 26
7.2.3 Broad Product Portfolio 27
7.3 Sorin S.p.A. Weaknesses 27
7.3.1 Product Recalls 27
7.3.2 Fluctuating Revenues 27
7.4 Sorin S.p.A. Opportunities 28
7.4.1 Market Growth in Emerging Markets 28
7.4.2 Regulatory Approvals and New Product Launches 28
7.4.3 Global Cardiovascular Devices Market 28
7.5 Sorin S.p.A. Threats 29
7.5.1 Competitive Landscape 29
7.5.2 Regulatory Environment 29
7.5.3 Rapid Technological Changes 29
8 Competitors 30
9 Competitive Landscape 31
9.1 Cardiovascular Devices (Cardiac Rhythm Management), Global, Market Share (%), 2011 31
9.2 Sorin S.p.A., Cardiovascular Devices (Cardiac Rhythm Management), by Region, Market Share (2011) 33
9.3 Sorin S.p.A., Cardiovascular Devices (Cardiac Rhythm Management), by Country, Market Share (2011) 34
9.4 Cardiovascular Devices (Cardiovascular Prosthetic Devices), Global, Market Share (%), 2011 36
9.5 Sorin S.p.A., Cardiovascular Devices (Cardiovascular Prosthetic Devices), by Region, Market Share (2011) 38
9.6 Sorin S.p.A., Cardiovascular Devices (Cardiovascular Prosthetic Devices), by Country, Market Share (2011) 39
9.7 Cardiovascular Devices (Cardiovascular Surgery), Global, Market Share (%), 2011 41
9.8 Sorin S.p.A., Cardiovascular Devices (Cardiovascular Surgery), by Region, Market Share (2011) 42
9.9 Sorin S.p.A., Cardiovascular Devices (Cardiovascular Surgery), by Country, Market Share (2011) 43
9.10 Cardiovascular Devices (Prosthetic Heart Valves), Global, Market Share (%), 2011 45
9.11 Sorin S.p.A., Cardiovascular Devices (Prosthetic Heart Valves), by Region, Market Share (2011) 46
9.12 Sorin S.p.A., Cardiovascular Devices (Prosthetic Heart Valves), by Country, Market Share (2011) 47
10 Sorin S.p.A. Medical Equipment Market Share Analysis by Category 49
10.1 Sorin S.p.A., Cardiovascular Devices, Global, Category Revenue Share (2011) 49
10.2 Sorin S.p.A., Asia-Pacific, Category Revenue Share (2011) 51
10.2.1 Sorin S.p.A., Australia, Category Revenue Share (2011) 53
10.2.2 Sorin S.p.A., China, Category Revenue Share (2011) 55
10.2.3 Sorin S.p.A., India, Category Revenue Share (2011) 57
10.2.4 Sorin S.p.A., Japan, Category Revenue Share (2011) 59
10.2.5 Sorin S.p.A., Other Asia-Pacific, Category Revenue Share (2011) 61
10.3 Sorin S.p.A., Europe, Category Revenue Share (2011) 63
10.3.1 Sorin S.p.A., France, Category Revenue Share (2011) 65
10.3.2 Sorin S.p.A., Germany, Category Revenue Share (2011) 67
10.3.3 Sorin S.p.A., Italy, Category Revenue Share (2011) 69
10.3.4 Sorin S.p.A., Spain, Category Revenue Share (2011) 71
10.3.5 Sorin S.p.A., United Kingdom, Category Revenue Share (2011) 73
10.3.6 Sorin S.p.A., Other Europe, Category Revenue Share (2011) 75
10.4 Sorin S.p.A., Middle East and Africa, Category Revenue Share (2011) 77
10.5 Sorin S.p.A., North America, Category Revenue Share (2011) 79
10.5.1 Sorin S.p.A., Canada, Category Revenue Share (2011) 81
10.5.2 Sorin S.p.A., United States, Category Revenue Share (2011) 83
10.6 Sorin S.p.A., South and Central America, Category Revenue Share (2011) 85
10.6.1 Sorin S.p.A., Brazil, Category Revenue Share (2011) 87
10.6.2 Sorin S.p.A., Other South and Central America, Category Revenue Share (2011) 89
11 Key Employees 91
12 Key Employee Biographies 92
13 Company Statement 93
14 Locations And Subsidiaries 96
14.1 Head Office 96
14.2 Other Locations & Subsidiaries 96
15 Financial Deals Landscape 98
15.1 Sorin S.p.A., Deals Volume Summary, 2007 to 2012 98
16 Sorin S.p.A. Detailed Deal Summary 100
16.1 Asset Purchase 100
16.1.1 Sorin Acquires Cannulae Product Line From ESTECH 100
16.1.2 Sorin Group Acquires EVH Business From Datascope 101
16.2 Venture Financing 102
16.2.1 HighLife Raises $6 Million In Venture Financing 102
16.2.2 Cardiosolutions Raises $8 Million In Venture Financing 103
16.3 Private Equity 104
16.3.1 Argos Soditic And MPS Venture SGR Acquire Bellco From Sorin 104
16.3.2 Sorin Group Sells Its Vascular Therapy Business To IP Investimenti e Partecipazioni 105
16.4 Partnerships 106
16.4.1 LETI Forms Partnership With Sorin, TIMA, Cedrat Technologies, Tronics And EASII IC 106
16.4.2 Sorin Enters Into Distribution Agreement With CardioMedical 107
16.4.3 Sorin Signs Distribution Agreement With Japan Lifeline 108
16.4.4 Sorin Enters Into Co-Development Agreement With Orange Business Services 109
16.4.5 Sorin Signs An Agreement With Sphere Medical 110
16.4.6 Sorin Enters Into An Agreement With Japan Lifeline 111
16.4.7 Sorin Signs Research Agreement With Mayo Clinic 112
16.5 Asset Transactions 113
16.5.1 Cytomedix Acquires Angel Whole Blood Separation System And activAT Autologous Thrombin Processing Kit From Sorin Group 113
16.5.2 Datascope Acquires Peripheral Vascular Stent Business From Sorin 115
16.6 Acquisition 116
16.6.1 Sorin Group Acquires Alcard Industria Mecanica, Cardiac Surgery Devices Maker 116
16.6.2 Sorin Group Acquires Neurotech, Developer Of Neurostimulation Devices 117
16.6.3 Sorin Acquires California Medical Labs, Maker Of Cardiovascular Cannulae, For $14 Million 119
16.6.4 Sorin Group Invests $7 Million In Enopace Biomedical 120
16.6.5 Sorin Group Acquires GISH Biomedical From VENTIZZ Capital Partners 121
16.6.6 Sorin Group Acquires Austria-Based Distributor For $4.8 Million 122
16.6.7 Sorin Acquires Minority Stake In Sphere Medical Holding 123
16.6.8 Japan Lifeline Acquires Sorin Group Japan From Sorin 124
17 Recent Developments 125
17.1 Financial Announcements 125
17.1.1 Oct 31, 2012: Sorin Reports Revenue Of Of €160.4m In Q3 2012 125
17.1.2 Jul 30, 2012: Sorin Reports Revenue Of €188.2m In Q2 2012 126
17.1.3 Apr 23, 2012: Sorin Reports Revenue Of €191.7m In Q1 2012 127
17.1.4 Mar 15, 2012: Sorin Reports Revenue Of €743.4m In 2011 128
17.1.5 Oct 28, 2011: Sorin Reports Revenue Of €171.4m In Q3 2011 129
17.1.6 Jul 29, 2011: Sorin Reports Total Revenues Of €191.9m For Q2 2011 131
17.1.7 Apr 29, 2011: Sorin Reports Net Revenues Of €182.3m In Q1 2011 131
17.1.8 Mar 17, 2011: Sorin Reports Net Profit of €39.1m In 2010 133
17.1.9 Oct 26, 2010: Sorin Reports Net Income Of $8.2 Million For Q3 2010 133
17.1.10 Oct 26, 2010: Sorin Reports Net Income Of EUR8.2 Million For Q3 2010 134
17.1.11 Oct 26, 2010: Sorin Reports Net Revenues Of EUR180.3 Million In Q3 2010 134
17.1.12 Jul 29, 2010: Sorin Reports Net Revenues Of EUR197.5 Million In Q2 2010 134
17.1.13 Apr 30, 2010: Sorin Reports Net Revenues Of EUR172.4 million In Q1 2010 135
17.1.14 Mar 19, 2010: Sorin Reports Revenues Of EUR689 Million In 2009 136
17.1.15 Oct 29, 2009: Sorin Reports Net Earnings Of EUR3.9 Million In Q3 2009 137
17.1.16 Jul 30, 2009: Sorin Reports Net Result Of EUR12.8 Million In Q2 2009 138
17.1.17 Apr 30, 2009: Sorin Posts Net Profit Of EUR2.8 Million For Q1 2009 140
17.1.18 Mar 19, 2009: Sorin Reports 2008 Results 141
17.1.19 Feb 10, 2009: Sorin Reports Preliminary Results For 2008 143
17.1.20 Nov 12, 2008: Sorin Reports 3Q 2008 Results 145
17.1.21 Aug 26, 2008: Sorin Reports 1H 2008 Results 147
17.1.22 Jul 25, 2008: Sorin Reports Preliminary 2Q 2008 Results 148
17.1.23 May 07, 2008: Sorin Declares Q1 2008 Results 150
17.1.24 Mar 28, 2008: Sorin Declares 2007 Results 152
17.1.25 Nov 08, 2007: Sorin Declares Q3 2007 Results 154
17.1.26 Sep 11, 2007: Sorin Declares H1 2007 Results 155
17.1.27 May 07, 2007: Sorin Declares Q1 2007 Results 156
17.1.28 Feb 13, 2007: Sorin Declares Q4 2006 Results 158
17.2 Corporate Communications 159
17.2.1 Jun 15, 2010: Sorin Co-opts Massimo Tononi As Member Of Board 159
17.2.2 May 17, 2010: Sorin Announces Resignation Of Giovanni Gorno Tempini As Board Member 159
17.2.3 May 14, 2010: Sorin’s Board Member Giovanni Gorno Tempini Resigns 159
17.2.4 Jun 26, 2009: Sorin Announces Board Resignations 159
17.2.5 Mar 19, 2009: Sorin Announces Board Changes 160
17.2.6 Jan 08, 2009: Sorin Announces Board And Management Changes 160
17.2.7 Nov 25, 2008: Sorin Announces Board Resignations 160
17.2.8 Oct 11, 2007: Sorin Appoints President, CRM Business Unit 161
17.2.9 Sep 21, 2007: Sorin Appoints New CEO 161
17.3 Legal and Regulatory 162
17.3.1 Mar 12, 2010: Sorin Announces Tentative Settlement Of Investigation By Department Of Justice 162
17.3.2 Dec 24, 2008: Sorin Settles Litigation With ATS Medical 162
17.4 Product News 163
17.4.1 Dec 04, 2012: Sorin Receives PMDA Approval And Announces Commercial Launch Of Mitroflow Aortic Pericardial Heart Valve In Japan 163
17.4.2 Sep 18, 2012: Sorin Group Announces CE Mark Approval Of Extended Indications And Second Generation Accessories For Perceval S 163
17.4.3 Jun 13, 2012: Sorin Group And Orange Business Services Launch SMARTVIEW 164
17.4.4 Jun 12, 2012: Sorin Announces First Enrollment In Dream Clinical Study 164
17.4.5 May 16, 2012: Sorin Group Receives Regulatory Approval To Market Memo 3D Annuloplasty Ring In Japan 165
17.4.6 May 09, 2012: Sorin Announces Publication Of Full Clear Study Results In Peer Reviewed Cardiology Journal 165
17.4.7 Feb 21, 2012: Sorin Announces Initiation Of US IDE Study Of Freedom Solo Stentless Pericardial Aortic Valve 166
17.4.8 Dec 05, 2011: Sorin Receives CE Mark For INSPIRE6 167
17.4.9 Oct 12, 2011: Sorin Launches SonR CRT Optimization System At Venice Arrhythmias 2011 Congress 167
17.4.10 Jul 28, 2011: Sorin Group Receives CE Mark Approval For Mitroflow Aortic Pericardial Heart Valve With PRT 168
17.4.11 May 24, 2011: Sorin Announces First North American Implant Of Freedom Solo Pericardial Aortic Valve 169
17.4.12 May 02, 2011: Sorin Launches VascuClear Endoscopic Vessel Harvesting System 169
17.4.13 Apr 29, 2011: Sorin Announces US Launch Of XTRA Autotransfusion System 170
17.4.14 Feb 21, 2011: Sorin Group Achieves Milestone In Mitroflow Aortic Pericardial Heart Valve 170
17.4.15 Jan 31, 2011: Sorin Group Receives CE Mark Approval For Perceval S Self-Anchoring Aortic Heart Valve 171
17.4.16 Sep 15, 2010: Sorin Announces Presentation Of Clinical Results Of Perceval S Self-Anchoring Aortic Heart Valve 172
17.4.17 Jun 17, 2010: Sorin Announces CLEAR Study For SonR Technology Met Its Primary Endpoint 172
17.4.18 Feb 18, 2010: Sorin Announces FDA Approval For New Generation C5 Heart-Lung Machine 173
17.4.19 Feb 05, 2010: Sorin Group Announces FDA Approval And First Implantation Of Paradym CRT Model 8750 174
17.4.20 Aug 15, 2009: Sorin Group To Complete Trial For FREEDOM SOLO In The Second Quarter Of 2014 174
17.4.21 Jul 07, 2009: Sorin Group Receives Health Canada TPD Approval To Market REPLY Pacemaker 175
17.4.22 Jul 03, 2009: Sorin Group Announces Japanese Regulatory Approval And First Implant Of REPLY And FACIL Pacemakers 175
17.4.23 Jun 25, 2009: Sorin Group Delivers Its 1000TH S5 Heart-Lung Machine 176
17.4.24 Feb 24, 2009: Sorin Group Kick Starts Patient Enrolment In European Trial For Perceval S Sutureless Aortic Valve 176
17.4.25 Dec 11, 2008: Sorin Group Announces The Japanese Approval And Market Release Of Defibrillation Lead-Isoline 177
17.4.26 Nov 26, 2008: Sorin Group Announces European Market Release And First Implant Of New-Generation Cardiac Resynchronization Therapy Defibrillator 177
17.4.27 Sep 16, 2008: Sorin Group Publishes 21 Year Durability Data Of It’s Mitroflow Aortic Pericardial Heart Valve 178
17.4.28 Sep 12, 2008: Sorin Group Announces First Successful Use Of New Pediatric Oxygenator At Children’s Medical Center Dallas 178
17.4.29 Sep 12, 2008: Sorin Group Announces Successful Use Of New Pediatric Arterial Filter At Children’s Medical Center Dallas 179
17.4.30 Aug 07, 2008: Sorin Group Announces FDA Approval And First US Implant Of The Dual Chamber Pacemaker 179
17.4.31 May 21, 2008: Sorin Group Reports FDA Approval Of Ovatio CRT 179
17.4.32 May 16, 2008: Sorin Group Announces FDA Approval Of The World’s Smallest Cardiac Resynchronization Implantable Cardioverter Defibrillator OVATIO CRT 180
17.4.33 Apr 28, 2008: Sorin Group Cardiac Rhythm Management Announces First Implant Of A New-Generation CRT-D Device Designed To Provide Hemodynamic Management Of Heart Failure 180
17.4.34 Mar 07, 2008: Sorin Group Announces FDA Approval Of New Defibrillation Leads Range: ISOLINE 181
17.4.35 Feb 14, 2008: Sorin Group Announces US Clinical Trial Of Memo 3D Semirigid Annuloplasty Ring 181
17.4.36 Dec 31, 2007: Mitroflow Aortic Pericardial Heart Valve Gets US FDA Approval In United states 182
17.4.37 Dec 05, 2007: Sorin Group Announces First US Implant Of Mitroflow Aortic Pericardial Heart Valve 182
17.4.38 Dec 03, 2007: Sorin Group Cardiac Rhythm Management Announces The First US Enrollment In The Option Study 182
17.4.39 Oct 22, 2007: Sorin Group Announces The First US Clinical Implant Of The World’s Smallest Cardiac Resynchronization Implantable Cardioverter Defibrillator – Ovatio CRT 183
17.4.40 Sep 25, 2007: Sorin Group Announces US FDA’s Authorization To Market Its Memo 3D Annuloplasty Ring In the United States 184
17.4.41 May 09, 2007: The Sorin Group Announces European Market Release Of REPLY, The World’s Smallest Pacemaker 184
17.4.42 Mar 08, 2007: First Implants And EU Approval For Sorin REPLY Pacemakers 184
17.5 Product Approvals 185
17.5.1 Sep 18, 2012: Sorin Group Announces CE Mark Approval Of Extended Indications And Second Generation Accessories For Perceval S 185
17.5.2 May 16, 2012: Sorin Group Receives Regulatory Approval To Market Memo 3D Annuloplasty Ring In Japan 185
17.5.3 Dec 05, 2011: Sorin Receives CE Mark For INSPIRE6 186
17.5.4 Jul 28, 2011: Sorin Group Receives CE Mark Approval For Mitroflow Aortic Pericardial Heart Valve With PRT 186
17.5.5 Jan 31, 2011: Sorin Group Receives CE Mark Approval For Perceval S Self-Anchoring Aortic Heart Valve 187
17.5.6 Feb 05, 2010: Sorin Group Announces FDA Approval And First Implantation Of Paradym CRT Model 8750 187
17.5.7 Jul 07, 2009: Sorin Group Receives Health Canada TPD Approval To Market REPLY Pacemaker 188
17.5.8 Jul 03, 2009: Sorin Group Announces Japanese Regulatory Approval And First Implant Of REPLY And FACIL Pacemakers 189
17.5.9 Dec 11, 2008: Sorin Group Announces The Japanese Approval And Market Release Of Defibrillation Lead-Isoline 189
17.5.10 Aug 07, 2008: Sorin Group Announces FDA Approval And First US Implant Of The Dual Chamber Pacemaker 190
17.5.11 May 21, 2008: Sorin Group Reports FDA Approval Of Ovatio CRT 190
17.5.12 May 16, 2008: Sorin Group Announces FDA Approval Of The World’s Smallest Cardiac Resynchronization Implantable Cardioverter Defibrillator OVATIO CRT 191
17.5.13 Mar 07, 2008: Sorin Group Announces FDA Approval Of New Defibrillation Leads Range: ISOLINE 191
17.5.14 Dec 31, 2007: Mitroflow Aortic Pericardial Heart Valve Gets US FDA Approval In United states 192
17.5.15 Sep 25, 2007: Sorin Group Announces US FDA’s Authorization To Market Its Memo 3D Annuloplasty Ring In the United States 192
17.5.16 Mar 08, 2007: First Implants And EU Approval For Sorin REPLY Pacemakers 192
17.6 Clinical Trials 193
17.6.1 Jun 12, 2012: Sorin Announces First Enrollment In Dream Clinical Study 193
17.6.2 Feb 21, 2012: Sorin Announces Initiation Of US IDE Study Of Freedom Solo Stentless Pericardial Aortic Valve 193
17.6.3 Sep 15, 2010: Sorin Announces Presentation Of Clinical Results Of Perceval S Self-Anchoring Aortic Heart Valve 194
17.6.4 Jun 17, 2010: Sorin Announces CLEAR Study For SonR Technology Met Its Primary Endpoint 195
17.6.5 Aug 15, 2009: Sorin Group To Complete Trial For FREEDOM SOLO In The Second Quarter Of 2014 195
17.6.6 Feb 24, 2009: Sorin Group Kick Starts Patient Enrolment In European Trial For Perceval S Sutureless Aortic Valve 196
17.6.7 Sep 16, 2008: Sorin Group Publishes 21 Year Durability Data Of It’s Mitroflow Aortic Pericardial Heart Valve 196
17.6.8 Apr 28, 2008: Sorin Group Cardiac Rhythm Management Announces First Implant Of A New-Generation CRT-D Device Designed To Provide Hemodynamic Management Of Heart Failure 197
17.6.9 Feb 14, 2008: Sorin Group Announces US Clinical Trial Of Memo 3D Semirigid Annuloplasty Ring 198
17.6.10 Dec 05, 2007: Sorin Group Announces First US Implant Of Mitroflow Aortic Pericardial Heart Valve 198
17.6.11 Dec 03, 2007: Sorin Group Cardiac Rhythm Management Announces The First US Enrollment In The Option Study 198
17.6.12 Oct 22, 2007: Sorin Group Announces The First US Clinical Implant Of The World’s Smallest Cardiac Resynchronization Implantable Cardioverter Defibrillator – Ovatio CRT 199
17.7 Other Significant Developments 200
17.7.1 Dec 08, 2010: SORIN Group Uses KIKA Advanced EDC Platform For Clinical Asset Management On Heart Valve Studies 200
17.7.2 Apr 16, 2009: Sorin Enters Ten-Year Distribution Agreement With JLL For Its Heart Valves Portfolio 200
18 Appendix 201
18.1 Research Methodology 202
18.2 Secondary Research 202
18.3 Primary Research 202
18.4 Models 203
18.5 Forecasts 203
18.6 Expert Panels 203
18.7 GlobalData Consulting 203
18.8 Currency Conversion 204
18.9 Contact Us 205
18.10 Disclaimer 205
【レポート販売概要】
■ タイトル：Sorin S.p.A.：市場シェア分析■ 英文：Sorin S.p.A. Market Share Analysis
■ 発行日：2013年2月28日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160559
■ 調査対象地域：グローバル
- UCaaSの世界市場2015-2019About Global Unified Communication as a Service Market UCaaS refers to integration of real-time business communication services such as voice messaging, video conferencing, text messages, and other mobility features delivered through cloud. Over the years, businesses worldwide are witnessing unprecedented dependence on various advanced technologies and adopting various integration solutions to run …
- 二硫化炭素の世界市場Carbon Disulphide (CAS 75-15-0) Market Research Report 2014 presents comprehensive data on carbon disulphide markets globally and regionally (Europe, Asia, North America etc.) The report includes carbon disulphide description, covers its application areas and related patterns. It overviews carbon disulphide market, names carbon disulphide producers and indicates its suppliers. Besides, the report …
- 再生可能エネルギーによる分散型発電(RDEG)技術のグローバル市場（2014-2018）About Renewable Distributed Energy Generation Technologies Renewable distributed energy generation includes small-scale renewable generation technologies such as solar PV, small wind, waste to energy, stationary fuel cell, micro CHP, and micro hydro. The capacity of these distributed renewable plants is very low compared to higher capacity renewable plants. Also, distributed solar PV capacity may …
- 無線ビデオ監視システムの世界市場2015-2019About Wireless Video Surveillance Video surveillance is the process of monitoring or observing the activities, behavior, or movements of individuals or groups, for enhanced security. It is used by retail stores, government departments, hospitals, transportation and logistics companies, and law enforcement agencies. However, video surveillance requires strong network infrastructure for efficient da …
- DCモーターの世界市場2016-2020About the DC Motors Market A DC motor is a synchronous motor that is powered by an electrical source using an integrated switching power supply. It has electronic commutation system, field windings, and armature. The armature or coil, which is wound on the rotor, conducts current. The commutator takes the stationary power of the armature, and passes it on to the brushes or conductive rods. DC moto …
- クラスDオーディオ・アンプの世界市場予測（～2022年）The Class D audio amplifier market is expected to be worth USD 2.76 Billion by 2022, growing at a CAGR of 17.4% between 2016 and 2022. The major drivers for the growth of this market are the usage of Class D audio amplifier in the in-car audio systems and consumer electronic devices such as smartphones, tablets, and televisions. The Class D audio amplifier technology is extensively used in consume …
- 道路輸送燃料の世界市場2019-2023About this market The rising urbanization and industrialization are one of the key factors expected to trigger the road transportation fuel market growth during the forecast period. Urban growth and transportation are often related to each other as urban population growth increases demand for travel, while urban development encompasses the development of transportation infrastructure. Furthermore, …
- インシュリンのグローバル市場（～2019）The industry report Global Insulin Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for insulin in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, marketing, sales and product manage …
- 世界の受動部品（レジスタ、キャパシタ、インダクタ）市場（2014-2018）About Passive Components A passive component is a module that does not require any source of energy to perform its function in any given application. Capacitors, inductors, and resistors are the main types of passive component. They are used to control the intensity of the current or voltage in a circuit. Passive components are used in industry to improve the energy efficiency, life, and performan …
- 世界のコーン油市場：種類別、地域別Global Maize Oil Market: About this market Technavio’s maize oil market analysis considers sales from both edible and non-edible types. Our study also finds the sales of maize oil in APAC, Europe, MEA, North America, and South America. In 2019, the edible segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the health benefits of …
- アフェレーシスの世界市場：血漿交換、血小板フェレーシス、赤血球アフェレーシス、白血球除去療法、循環光療法Apheresis is an essential tool in modern medical practices in the blood industry. It is a process in which the blood of a donor/patient is passed through a medical device, which separates one or more components of the blood and returns the remaining with or without extracorporeal treatment or replacement of separated components. The global apheresis market is expected to reach USD 2.5 billion by 2 …
- 尿酸の市場別医療検査数および販売予測This new report from Venture Planning Group provides analysis of Uric Acid testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories P …
- タイヤ物流の世界市場ABSTRACTAbout Tire Logistics Logistics and supply chains for spare parts are unstable when compared with market finished products. Many manufacturing companies are facing setbacks because of an increase in operational costs and a decline in demand from consumers. Vendors of logistics services need to be efficient at services such as data management, IT, and supply chain management. Accurate foreca …
- ネットワーク対応兵器（NEW)の世界市場2018-2022About Network Enabled Weapons (NEW) NEWs are an emerging class of precision-guided munitions that are derivatives of conventional GPS-guided weapons. These weapons can feature the capability of altering or updating their respective targeting coordinates during mid-flight. Technavio’s analysts forecast the global network enabled weapons (NEW) market to grow at a CAGR of 13.84% during the period 201 …
- 世界のビジネスプロセス管理(BPM)市場動向（2012-2016）TechNavio's analysts forecast the Global Business Process Management (BPM) market to grow at a CAGR of 14.03 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to improve productivity and gain a competitive advantage. The Global BPM market has also been witnessing the increased demand for cloud-based solutions. However, the high implementation …
